ABSTRACT
Objective: Several randomized trials have been done to compare fluoroquinolones alone with the combination therapy of β-lactams plus macrolides for treating community-acquired pneumonia (CAP) in adults. However, the efficacy and safety between the two arms are still unclear.
Methods: We searched the PubMed, Embase, ScienceDirect and China National Knowledge Infrastructure (CNKI). Two reviewers independently extracted data and the mortality, treatment success and adverse events were compared between fluoroquinolones and β-lactams plus macrolides. RevMan 5.0 was used for statistical analysis.
Results: 11 randomized controlled trials were included in our meta-analysis. Mortality was not significantly different for fluoroquinolones vs. β-lactams plus macrolides (OR 1.29, 95% CI 0.73–2.27). Treatment success was higher with fluoroquinolones both in the intention-to-treat (ITT) population (OR 1.37, 95% CI 1.02–1.83) and the clinically evaluable population (OR 1.34, 95% CI 1.01–1.79). No difference was found between fluoroquinolones and β-lactams plus macrolides in microbiological treatment success (OR = 1.31, 95% CI 0.82-2.09).
Conclusions: Our meta-analysis suggested that fluoroquinolones were more effective than β-lactams plus macrolides for the treatment of CAP and the safety of the two therapies were similar.
Manuscripts that are “Published at Acceptance” have been peer reviewed and accepted for publication by the Editorial Board of the West Indian Medical Journal. They may appear prior to being copy edited or formatted in the style guide of this Journal. The contents of the manuscript may change before it is published in its final form. While accepted manuscripts are not yet assigned a volume, issue, or page numbers, they can be cited using the DOI and date of e-publication. See our Instructions for Authors on how to properly cite manuscripts at this stage. Manuscripts in this section will be removed once they have been assigned to a volume and issue, but will still retain the DOI and date of e-publication.